Platelet-activating factor receptor contributes to host defense against Pseudomonas aeruginosa pneumonia but is not essential for the accompanying inflammatory and procoagulant response

Journal of Immunology

Volumn 180, Issue 5, 2008, Pages 3357-3365

  Van Zoelen, Marieke A D ^a,b   Florquin, Sandrine ^a   Meijers, Joost C M ^a   De Beer, Regina ^a   De Vos, Alex F ^a   De Boer, Onno J ^a   Van Der Poll, Tom ^a  

^a UNIVERSITY OF AMSTERDAM   (Netherlands)

^b ACADEMIC MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE; D DIMER; PROCOAGULANT; THROMBIN ANTITHROMBIN COMPLEX; THROMBOCYTE ACTIVATING FACTOR RECEPTOR; AUTACOID; FIBRINOGEN RECEPTOR; G PROTEIN COUPLED RECEPTOR; THROMBOCYTE ACTIVATING FACTOR;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BACTERIAL GROWTH; BLOOD CLOTTING; BLOOD LEVEL; CONTROLLED STUDY; GENE DELETION; GRANULOCYTE; HISTOPATHOLOGY; HOST RESISTANCE; IMMUNE RESPONSE; IN VITRO STUDY; INFLAMMATION; INNATE IMMUNITY; LUNG HOMOGENATE; LUNG INJURY; LUNG LAVAGE; LUNG PARENCHYMA; LUNG WEIGHT; MALE; MOUSE; NEUTROPHIL; NONHUMAN; PHAGOCYTOSIS; PLASMA; PRIORITY JOURNAL; PSEUDOMONAS AERUGINOSA; PSEUDOMONAS PNEUMONIA; WILD TYPE; ANIMAL; BACTERIAL PNEUMONIA; C57BL MOUSE; GENETICS; GRAM NEGATIVE INFECTION; METABOLISM; MOUSE MUTANT; PATHOLOGY; PHYSIOLOGY;

ANIMALS; INFLAMMATION MEDIATORS; MALE; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; PLATELET ACTIVATING FACTOR; PLATELET MEMBRANE GLYCOPROTEINS; PNEUMONIA, BACTERIAL; PSEUDOMONAS INFECTIONS; RECEPTORS, G-PROTEIN-COUPLED;

EID: 49149108070     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.180.5.3357     Document Type: Article

References (52)

1. Bergogne-Berezin, E. 1995. Treatment and prevention of nosocomial pneumonia. Chest 108: 26S-34S.
2. Sadikot, R. T., T. S. Blackwell, J. W. Christman, and A. S. Prince. 2005. Pathogen-host interactions in Pseudomonas aeruginosa pneumonia. Am. J. Respir. Crit. Care Med. 171: 1209-1223.
3. Chastre, J., and J. Y. Fagon. 2002. Ventilator-associated pneumonia. Am. J. Respir. Crit. Care Med. 165: 867-903.
4. Mesaros, N., P. Nordmann, P. Plesiat, M. Roussel-Delvallez, J. van Eldere, Y. Glupczynski, Y. van Laethem, F. Jacobs, P. Lebecque, A. Malfroot, et al. 2007. Pseudomonas aeruginosa: resistance and therapeutic options at the turn of the new millennium. Clin. Microbiol. Infect. 13: 560-578.
5. Ishii, S., and T. Shimizu. 2000. Platelet-activating factor (PAF) receptor and genetically engineered PAF receptor mutant mice. Prog. Lipid Res. 39: 41-82.
6. Prescott, S. M., G. A. Zimmerman, D. M. Stafforini, and T. M. McIntyre. 2000. Platelet-activating factor and related lipid mediators. Annu. Rev. Biochem. 69: 419-445.
7. Bulger, E. M., S. Arbabi, I. Garcia, and R. V. Maier. 2002. The macrophage response to endotoxin requires platelet activating factor. Shock 17: 173-179.
8. Owaki, T., A. Meneshian, K. Maemura, S. Takao, D. Wang, K. C. Fuh, G. B. Bulkley, and A. S. Klein. 2000. Endothelial cells potentiate phagocytic killing by macrophages via platelet-activating factor release. Am. J. Physiol. 278: H269-H276.
9. Aliberti, J. C., F. S. Machado, R. T. Gazzinelli, M. M. Teixeira, and J. S. Silva. 1999. Platelet-activating factor induces nitric oxide synthesis in Trypanosoma cruzi-infected macrophages and mediates resistance to parasite infection in mice. Infect. Immun. 67: 2810-2814.
10. Soares, A. C., V. S. Pinho, D. G. Souza, T. Shimizu, S. Ishii, J. R. Nicoli, and M. M. Teixeira. 2002. Role of the platelet-activating factor (PAF) receptor during pulmonary infection with gram negative bacteria. Br. J. Pharmacol. 137: 621-628.
11. Nagase, T., S. Ishii, K. Kume, N. Uozumi, T. Izumi, Y. Ouchi, and T. Shimizu. 1999. Platelet-activating factor mediates acid-induced lung injury in genetically engineered mice. J. Clin. Invest. 104: 1071-1076.
12. Lee, Y. M., B. M. Hybertson, H. G. Cho, and J. E. Repine. 2002. Platelet-activating factor induces lung inflammation and leak in rats: hydrogen peroxide production along neutrophil-lung endothelial cell interfaces. J. Lab. Clin. Med. 140: 312-319.
13. Lee, Y. M., B. M. Hybertson, H. G. Cho, L. S. Terada, O. Cho, A. J. Repine, and J. E. Repine. 2000. Platelet-activating factor contributes to acute lung leak in rats given interleukin-1 intratracheally. Am. J. Physiol. 279: L75-L80.
14. Cundell, D. R., N. P. Gerard, C. Gerard, I. Idanpaan-Heikkila, and E. I. Tuomanen. 1995. Streptococcus pneumoniae anchor to activated human cells by the receptor for platelet-activating factor. Nature 377: 435-438.
15. Fischer, W. 2000. Phosphocholine of pneumococcal teichoic acids: role in bacterial physiology and pneumococcal infection. Res. Microbiol. 151: 421-427.
16. Risberg, A., G. Alvelius, and E. K. Schweda. 1999. Structural analysis of the lipopolysaccharide oligosaccharide epitopes expressed by Haemophilus influenzae strain RM.118-26. Eur. J. Biochem. 265: 1067-1074.
17. Rijneveld, A. W., S. Weijer, S. Florquin, P. Speelman, T. Shimizu, S. Ishii, and T. van der Poll. 2004. Improved host defense against pneumococcal pneumonia in platelet-activating factor receptor-deficient mice. J. Infect. Dis. 189: 711-716.
18. van der Sluijs, K. F., L. J. van Elden, M. Nijhuis, R. Schuurman, S. Florquin, T. Shimizu, S. Ishii, H. M. Jansen, R. Lutter, and T. van der Poll. 2006. Involvement of the platelet-activating factor receptor in host defense against Streptococcus pneumoniae during postinfluenza pneumonia. Am. J. Physiol. 290: L194-L199.
19. Branger, J., C. W. Wieland, S. Florquin, N. A. Maris, J. M. Pater, P. Speelman, T. Shimizu, S. Ishii, and T. van der Poll. 2004. Platelet-activating factor receptor-deficient mice show an unaltered clearance of nontypeable Haemophilus influenzae from their respiratory tract. Shock 22: 543-547.
20. Ishii, S., T. Kuwaki, T. Nagase, K. Maki, F. Tashiro, S. Sunaga, W. H. Cao, K. Kume, Y. Fukuchi, K. Ikuta, et al. 1998. Impaired anaphylactic responses with intact sensitivity to endotoxin in mice lacking a platelet-activating factor receptor. J. Exp. Med. 187: 1779-1788.
21. Schultz, M. J., S. Knapp, S. Florquin, J. Pater, K. Takeda, S. Akira, and T. van der Poll. 2003. Interleukin-18 impairs the pulmonary host response to Pseudomonas aeruginosa. Infect. Immun. 71: 1630-1634.
22. Ramphal, R., V. Balloy, M. Huerre, M. Si-Tahar, and M. Chignard. 2005. TLRs 2 and 4 are not involved in hypersusceptibility to acute Pseudomonas aeruginosa lung infections. J. Immunol. 175: 3927-3934.
23. Gosselin, D., J. DeSanctis, M. Boule, E. Skamene, C. Matouk, and D. Radzioch. 1995. Role of tumor necrosis factor β in innate resistance to mouse pulmonary infection with Pseudomonas aeruginosa. Infect. Immun. 63: 3272-3278.
24. Schultz, M. J., A. W. Rijneveld, S. Florquin, C. K. Edwards, C. A. Dinarello, and T. van der Poll. 2002. Role of interleukin-1 in the pulmonary immune response during Pseudomonas aeruginosa pneumonia. Am. J. Physiol. 282: L285-L290.
25. Rijneveld, A. W., S. Weijer, S. Florquin, C. T. Esmon, J. C. Meijers, P. Speelman, P. H. Reitsma, H. Ten Cate, and T. van der Poll. 2004. Thrombomodulin mutant mice with a strongly reduced capacity to generate activated protein C have an unaltered pulmonary immune response to respiratory pathogens and lipopolysaccharide. Blood 103: 1702-1709.
26. Knapp, S., C. W. Wieland, C. van 't Veer, O. Takeuchi, S. Akira, S. Florquin, and T. van der Poll. 2004. Toll-like receptor 2 plays a role in the early inflammatory response to murine pneumococcal pneumonia but does not contribute to antibacterial defense. J. Immunol. 172: 3132-3138.
27. Wieland, C. W., S. Florquin, N. A. Maris, K. Hoebe, B. Beutler, K. Takeda, S. Akira, and T. van der Poll. 2005. The MyD88-dependent, but not the MyD88-independent, pathway of TLR4 signaling is important in clearing nontypeable Haemophilus influenzae from the mouse lung. J. Immunol. 175: 6042-6049.
28. Renckens, R., J. J. Roelofs, S. Florquin, A. F. de Vos, H. R. Lijnen, C. Van't Veer, and T. van der Poll. 2006. Matrix metalloproteinase-9 deficiency impairs host defense against abdominal sepsis. J. Immunol. 176: 3735-3741.
29. Renckens, R., J. J. Roelofs, S. Florquin, A. F. de Vos, J. M. Pater, H. R. Lijnen, P. Carmeliet, and T. van der Poll. 2006. Endogenous tissue-type plasminogen activator is protective during Escherichia coli-induced abdominal sepsis in mice. J. Immunol. 177: 1189-1196.
30. Knapp, S., U. Matt, N. Leitinger, and T. van der Poll. 2007. Oxidized phospholipids inhibit phagocytosis and impair outcome in Gram-negative sepsis in vivo. J. Immunol. 178: 993-1001.
31. Blander, J. M., and R. Medzhitov. 2004. Regulation of phagosome maturation by signals from Toll-like receptors. Science 304: 1014-1018.
32. Leemans, J. C., M. J. Vervoordeldonk, S. Florquin, K. P. van Kessel, and T. van der Poll. 2002. Differential role of interleukin-6 in lung inflammation induced by lipoteichoic acid and peptidoglycan from Staphylococcus aureus. Am. J. Respir. Crit. Care Med. 165: 1445-1450.
33. Weijer, S., S. H. Schoenmakers, S. Florquin, M. Levi, G. P. Vlasuk, W. E. Rote, P. H. Reitsma, C. A. Spek, and T. van der Poll. 2004. Inhibition of the tissue factor/factor VIIa pathway does not influence the inflammatory or antibacterial response to abdominal sepsis induced by Escherichia coli in mice. J. Infect. Dis. 189: 2308-2317.
34. Zhang, P., W. R. Summer, G. J. Bagby, and S. Nelson. 2000. Innate immunity and pulmonary host defense. Immunol. Rev. 173: 39-51.
35. Knapp, S., M. J. Schultz, and T. van der Poll. 2005. Pneumonia models and innate immunity to respiratory bacterial pathogens. Shock 24 (Suppl. 1): 12-18.
36. Olson, T. S., and K. Ley. 2002. Chemokines and chemokine receptors in leukocyte trafficking. Am. J. Physiol 283: R7-R28.
37. Walley, K. R., N. W. Lukacs, T. J. Standiford, R. M. Strieter, and S. L. Kunkel. 1997. Elevated levels of macrophage inflammatory protein 2 in severe murine peritonitis increase neutrophil recruitment and mortality. Infect. Immun. 65: 3847-3851.
38. Gunther, A., P. Mosavi, S. Heinemann, C. Ruppert, H. Muth, P. Markart, F. Grimminger, D. Walmrath, B. Temmesfeld-Wollbruck, and W. Seeger. 2000. Alveolar fibrin formation caused by enhanced procoagulant and depressed fibrinolytic capacities in severe pneumonia: comparison with the acute respiratory distress syndrome. Am. J. Respir. Crit. Care Med. 161: 454-462.
39. Schultz, M. J., J. J. Haitsma, H. Zhang, and A. S. Slutsky. 2006. Pulmonary coagulopathy as a new target in therapeutic studies of acute lung injury or pneumonia: a review. Crit. Care Med. 34: 871-877.
40. Kumasaka, T., N. A. Doyle, W. M. Quinlan, L. Graham, and C. M. Doerschuk. 1996. Role of CD 11/CD 18 in neutrophil emigration during acute and recurrent Pseudomonas aeruginosa-induced pneumonia in rabbits. Am. J. Pathol. 148: 1297-1305.
41. Qin, L., W. M. Quinlan, N. A. Doyle, L. Graham, J. E. Sligh, F. Takei, A. L. Beaudet, and C. M. Doerschuk. 1996. The roles of CD11/CD18 and ICAM-1 in acute Pseudomonas aeruginosa-induced pneumonia in mice. J. Immunol. 157: 5016-5021.
42. Gyetko, M. R., S. Sud, T. Kendall, J. A. Fuller, M. W. Newstead, and T. J. Standiford. 2000. Urokinase receptor-deficient mice have impaired neutrophil recruitment in response to pulmonary Pseudomonas aeruginosa infection. J. Immunol. 165: 1513-1519.
43. Coelho, F. M., A. C. Pessini, A. M. Coelho, V. S. Pinho, D. G. Souza, E. C. Arantes, M. M. Teixeira, and A. L. Teixeira. 2007. Platelet activating factor receptors drive CXC chemokine production, neutrophil influx, and edema formation in the lungs of mice injected with Tityus serrulatus venom. Toxicon 50: 420-427.
44. Au, B. T., M. M. Teixeira, P. D. Collins, and T. J. Williams. 2001. Blockade of PAF receptors controls interleukin-8 production by regulating the activation of neutrophil CD11/CD18. Eur. J. Pharmacol. 425: 65-71.
45. Moreno, S. E., J. C. Alves-Filho, F. Rios-Santos, J. S. Silva, S. H. Ferreira, F. Q. Cunha, and M. M. Teixeira. 2006. Signaling via platelet-activating factor receptors accounts for the impairment of neutrophil migration in polymicrobial sepsis. J. Immunol. 177: 1264-1271.
46. Rijneveld, A. W., S. Weijer, P. Bresser, S. Florquin, G. P. Vlasuk, W. E. Rote, C. A. Spek, P. H. Reitsma, J. S. van der Zee, M. Levi, and T. van der Poll. 2006. Local activation of the tissue factor-factor VIIa pathway in patients with pneumonia and the effect of inhibition of this pathway in murine pneumococcal pneumonia. Crit. Care Med. 34: 1725-1730.
47. Choi, G., M. J. Schultz, J. W. van Till, P. Bresser, J. S. van der Zee, M. A. Boermeester, M. Levi, and T. van der Poll. 2004. Disturbed alveolar fibrin turnover during pneumonia is restricted to the site of infection. Eur. Respir. J. 24: 786-789.
48. Schultz, M. J., J. Millo, M. Levi, C. E. Hack, G. J. Weverling, C. S. Garrard, and T. van der Poll. 2004. Local activation of coagulation and inhibition of fibrinolysis in the lung during ventilator associated pneumonia. Thorax 59: 130-135.
49. Schultz, M. J., and M. Levi. 2007. Pulmonary coagulopathy: a potential therapeutic target in different forms of lung injury. Thorax 62: 563-564.
50. Laterre, P. F., X. Wittebole, and J. F. Dhainaut. 2003. Anticoagulant therapy in acute lung injury. Crit. Care Med. 31: S329-S336.
51. Lorant, D. E., G. A. Zimmerman, T. M. McIntyre, and S. M. Prescott. 1995. Platelet-activating factor mediates procoagulant activity on the surface of endothelial cells by promoting leukocyte adhesion. Semin. Cell. Biol. 6: 295-303.
52. Yokota, Y., N. Inamura, M. Asano, Y. Yamamoto, K. Nakahara, Y. Notsu, T. Ono, and M. Watanabe. 1994. Effect of FR128998, a novel PAF receptor antagonist, on endotoxin-induced disseminated intravascular coagulation. Eur. J. Pharmacol. 258: 239-246.